Concourse Financial Group Securities’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 94 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2307 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2304 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2356 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2363 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2330 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2360 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2385 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2415 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2350 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2044 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2228 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2202 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2407 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2439 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2395 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2367 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2320 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2188 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2104 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2190 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2080 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1774 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2235 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2282 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2145 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1674 |
|